Introduction: The late screening of the majority of patients in sub Saharan region would justify a systematic antiretroviral treatment without
Introduction

Human immunodeficiency virus (HIV) infection is
. A few years ago, initiation of antiretroviral treatment (ART) passed first by the evaluation of some eligibility criteria to the treatment which will help the physicians to categorize people living with HIV (PLWHIV) with a view of their best ART. These criteria have evolved with time according to the aims in view. At the beginning, the objective was to treat the Acquired immunodeficiency syndrome (AIDS) stage in order to reduce mortality and as much as possible to avoid the side effects related to the antiretroviral one [4] . Currently, the treatment goal is to minimize the viral load in order to stop the infection progression and to best restore and as soon as possible the different immune functions destroyed by HIV virus. Accordingly, World Health Organization (WHO) now recommends the treatment of a positive patient newly detected for the HIV systematically regardless CD4 count [5] . Ultimately, there are no more eligibility criteria for starting an ART.
Unfortunately, sub-Saharan Africa, the area most strongly concerned by the HIV by concentrating 67% of the PLWHIV and 75% of deaths due to the AIDS [1], is characterized by a low socioeconomic level of its population and a significant number of hospitals and health centers insufficiently equipped [6] . Thus, almost all of country programs of fight against the HIV in this area are supported by international organizations. These ones usually lay down guidelines in order to optimize the treatment of vulnerable firstly [7] . This vision, if it persists, could be an obstacle for implementation of WHO current recommendations. However, from the late screening viewpoint of most patients in sub-Saharan Africa usually at the advanced stage of the disease, these ones could start ART systematically without breaking the eligibility criteria of treatment theoretically more rational based on the CD4 count [6] .
Thus, this work would like to assess the validity of the biological eligibility criteria to the antiretroviral treatment compared with the systematic antiretroviral treatment as recommended by WHO.
Methods
Study design
This retrospective study has systematically included the medical records of all adults HIV seropositive patients >15 years followed in 
Data collection
For each patient, socio-demographic parameters were recorded (age, sex, marital status).Then, the medical history of HIV infection was studied (the presence of opportunistic infections). Finally, the CD4 count at admission was searched.
Study outcomes
The systematic antiretroviral treatment was to initiate ART for all adults with HIV regardless of WHO clinical stage and at any CD4 cell count [5] . Previously recommended ART for this population was to Initiate ART for all adults with HIV and a CD4 count at or below 500 cells/mm 3 [7] . In this study, On the basis of biological criteria, the PLWHIV with CD4 < 500/mm 3 and/or if he is married (bride or divorced or widowed) and/or having an active tuberculosis were eligible to the treatment [7] . 
Statistical analyses
Results
General characteristics of the studied population Table 2 shows the results of the construction of the ROC curve.
Validity of the eligibility criteria to treatment
Compared with the "systematic antiretroviral treatment", the biological criteria of treatment eligibility had a sensitivity of 94.9%, a specificity of 100% and an AUC of 0.97 (0.96 to 0.98) (p <0.0001). The correlation coefficient was 0.88.
Discussion
The present study shows that 95.5% of the PLWHIV were at once eligible to the ART according to the biological criteria. In the same way, compared with the systematic treatment, the biological criteria had sensitivity and specificity respectively of 95.0% and 100% as 
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